Pilot Study of the Efficacy and Safety of Sirolimus in the Treatment of Congenital Hyperinsulinism.
Phase of Trial: Phase I/II
Latest Information Update: 18 Oct 2017
At a glance
- Drugs Sirolimus (Primary)
- Indications Hyperinsulinaemia
- Focus Therapeutic Use
- 19 Sep 2017 Planned End Date changed from 1 Jun 2017 to 1 Jun 2018.
- 19 Sep 2017 Planned primary completion date changed from 1 Jun 2017 to 1 Jun 2018.
- 15 Sep 2015 Status changed from not yet recruiting to recruiting, as reported by ClinicalTrials.gov.